Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02103478
Title Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

bone marrow cancer

Therapies

Decitabine and Cedazuridine

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.